Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00685048 · ClinicalTrials.gov registry record · NA

Brief Therapies for Problem Gambling Substance Abusers

A NA study, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
220
Enrollment target

NCT00685048: Completed NA study, sponsored by UConn Health.

NCT00685048 is a NA study that has completed, run by UConn Health. The registered enrollment target is 220 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00685048, a NA study, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target

Study Summary

This project evaluates the efficacy of brief interventions for individuals seeking treatment for substance use disorders who also have gambling problems. In total, 220 problem gambling substance abusers will be randomized to one of three conditions: (a) a control condition consisting of 10 minutes of psychoeducation about gambling, (b) 10 minutes of brief advice about problem gambling and how to reduce it, or (c) four session of motivational and cognitive-behavioral therapy. Gambling, substance use and psychosocial problems will be assessed using standardized instruments at pre-treatment, month 2, 5, 8, 12, 16, 20 and 24-month follow-up evaluations.

Interventions

  • BEHAVIORAL 10 minutes of psycho-education
  • BEHAVIORAL 10 minutes of brief advice
  • BEHAVIORAL four 50-minute individual therapy sessions of MET & CBT

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2007-07
Est. Completion 2014-01
Phase NA
UConn Health

178 total trials

What the finished NCT00685048 record still lists

NCT00685048 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 3 interventions - of which 10 minutes of psycho-education is the first listed.

NCT00685048 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00685048 about?

NCT00685048 is a clinical study titled "Brief Therapies for Problem Gambling Substance Abusers". This project evaluates the efficacy of brief interventions for individuals seeking treatment for substance use disorders who also have gambling problems. In total, 220 problem gambling substance abusers will be randomized to one of three conditions: (a) a control condition consisting of 10 minutes o...

What is the current status of trial NCT00685048?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2007-07. Estimated completion is 2014-01.

What interventions are being tested in trial NCT00685048?

The interventions under investigation include: 10 minutes of psycho-education (BEHAVIORAL), 10 minutes of brief advice (BEHAVIORAL), four 50-minute individual therapy sessions of MET & CBT (BEHAVIORAL).

Who is sponsoring clinical trial NCT00685048?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00685048's enrollment target sits among peer trials

220 481st of 2000 higher than 1,516 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00685048, the US trial registry maintained by the National Library of Medicine. NCT00685048 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.